/5
0 avis
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies
Archive ouverte
Edité par CCSD ; Lippincott, Williams & Wilkins -
International audience
Consulter en ligne
Chargement des enrichissements...